News
-
-
PRESS RELEASE
D. Boral Capital Acted as Sole Bookrunner to Apimeds Pharmaceuticals US, Inc. (NYSE:APUS) in connection with its $13.5 Million Initial Public Offering
Apimeds Pharmaceuticals US, Inc. closes IPO with 3,375,000 shares at $4.00 per share. Proceeds to fund clinical trials and product manufacturing -
-
-
PRESS RELEASE
D. Boral Capital Acted as Exclusive Placement Agent to ADS-TEC Energy (Nasdaq: ADSE) in connection with its up to $50.0 Million Registered Direct Offering
ADS-TEC Energy secures $50M from investors to expand in Europe & North America, transitioning to full-service provider for EV charging & energy trading, targeting recurring revenue -
-
-
PRESS RELEASE
D. Boral Capital Acted as Exclusive Placement Agent to Pineapple Financial Inc. (NYSE:PAPL) in Connection with its $1.5 Million Public Offering
Pineapple Financial Inc. closes public offering generating $1.5M. D. Boral Capital LLC serves as exclusive placement agent. Sichenzia Ross Ference Carmel LLP and Lucosky Brookman LLP act as legal counsels -
-